<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-02-17 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-02-17/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-02-17"><meta property="og:description" content="ğŸ“… Daily Report - 2026-02-17 ä»Šæ—¥ç­›é€‰å‡º 38 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-02-17T00:00:00+00:00"><meta property="article:modified_time" content="2026-02-17T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week082026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-02-17"><meta itemprop=description content="ğŸ“… Daily Report - 2026-02-17 ä»Šæ—¥ç­›é€‰å‡º 38 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-02-17T00:00:00+00:00"><meta itemprop=dateModified content="2026-02-17T00:00:00+00:00"><meta itemprop=wordCount content="2359"><meta itemprop=keywords content="Research,Daily,Week082026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-02-17"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-02-17 ä»Šæ—¥ç­›é€‰å‡º 38 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-17</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-02-17T00:00:00Z>2026-02-17</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-02-17>ğŸ“… Daily Report - 2026-02-17</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>38</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
GSE318408/GSE318867/GSE318663æ­ç¤ºè¡€ç®¡STINGæ¿€æ´»ä¿ƒè¿›å°ç»†èƒè‚ºç™Œï¼ˆSCLCï¼‰NKç»†èƒæŠ—è‚¿ç˜¤å…ç–«ï¼Œä¸ºSCLCå…ç–«æ²»ç–—æä¾›æ–°é¶ç‚¹ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å…ç–«ä¸å¾®ç¯å¢ƒè°ƒæ§ï¼ˆSCLCã€åµå·¢ç™Œã€å‰åˆ—è…ºç™Œã€è‚ºç™Œï¼‰</li><li>ç¥ç»ç³»ç»Ÿå‘è‚²ä¸ç–¾ç—…ï¼ˆé˜¿å°”èŒ¨æµ·é»˜ç—…ã€è„‘å‘è‚²ï¼‰</li><li>ç»†èƒä»£è°¢ä¸ç‚ç—‡ï¼ˆæ–°ç”Ÿå„¿è´¥è¡€ç—‡ï¼‰</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ•´åˆå•ç»†èƒRNA-seqä¸ATAC-seqï¼ˆGSE309579ï¼‰å®ç°å¯¹è‚¿ç˜¤åŸºå› è°ƒæ§åŠ¨åŠ›å­¦çš„ç²¾ç»†è§£æã€‚</li><li>ç©ºé—´è½¬å½•ç»„å­¦ï¼ˆGSE318867ï¼‰ç»“åˆåŸºå› ç»„å­¦åˆ†æï¼Œæ­ç¤ºè‚¿ç˜¤å¾®ç¯å¢ƒä¸­ç»†èƒé—´çš„ç›¸äº’ä½œç”¨ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
AIæ­ç¤ºé˜¿å°”èŒ¨æµ·é»˜ç—…åŸºå› è°ƒæ§æ–°æœºåˆ¶ï¼Œå‘ç°èƒ½åŠ é€ŸDNAé‡ç»„çš„é…¶N4BP2æ˜¯å¤šç§ç™Œç—‡çš„å…³é”®é©±åŠ¨å› ç´ ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>é˜¿å°”èŒ¨æµ·é»˜ç—…ï¼šåˆ©ç”¨AIç»˜åˆ¶å¤§è„‘åŸºå› è°ƒæ§å›¾è°±ï¼Œç†è§£ç–¾ç—…å‘ç”Ÿæœºåˆ¶ã€‚</li><li>èƒ°è…ºç™Œï¼šæ­ç¤ºç¥ç»ç³»ç»Ÿä¸èƒ°è…ºç™Œç»†èƒçš„ååŒä½œç”¨ï¼ŒåŠ é€Ÿæ—©æœŸç™Œç—‡è¿›ç¨‹ã€‚</li><li>ç™Œç—‡DNAé‡ç»„ï¼šå‘ç°N4BP2é…¶æ˜¯å¯¼è‡´æŸ“è‰²ä½“ç²‰ç¢æ€§é‡æ’ï¼ˆchromothripsisï¼‰çš„å…³é”®ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>SIGNETï¼šæ–°å‹AIç³»ç»Ÿï¼Œç”¨äºç»˜åˆ¶é˜¿å°”èŒ¨æµ·é»˜ç—…å¤§è„‘çš„åŸºå› è°ƒæ§ç½‘ç»œã€‚</li><li>æŸ“è‰²ä½“ç²‰ç¢æ€§é‡æ’ï¼ˆChromothripsisï¼‰æœºåˆ¶ï¼šé¦–æ¬¡å‘ç°N4BP2é…¶åœ¨å…¶ä¸­æ‰®æ¼”çš„è§’è‰²ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (34æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE318408 è¡€ç®¡ STING æ¿€æ´»ä¿ƒè¿›å°ç»†èƒè‚ºç™Œä¸­ NK ç»†èƒçš„æŠ—è‚¿ç˜¤å…ç–« [scRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€NK cellã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Marco Campisi ; Tatsuya Osaki ; David A Barbie ; Navin R MahadevanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensSmall cell lung cancer (SCLC) typically displays a &ldquo;cold&rdquo; tumor microenvironment with a paucity of immune infiltrate. Neuroendocrine SCLC cells also profoundly repress MHC-I expression, rendering them vulnerable to NK cell-mediated cytotoxicity. Here, we confirm that neuroendocrine SCLC cells are sensitive to NK cell mediated attack, yet quantitative spatial profiling of the SCLC immune microenvironment in patient samples reveals that effector immune cells, including NK cells, are excluded from MHC-Ilow/neg SCLC regions. To study this biology, we develop dynamic single cell RNA sequencing of microphysiological immune tumor environments (DynaMITE-seq) and integrate findings with spatial transcriptomics in patient tissue, unveiling the microvasculature as a major checkpoint restricting NK cell extravasation/recruitment. We demonstrate that activation of vascular Stimulator of Interferon Genes (STING) signaling restores NK cell infiltration and killing of neuroendocrine SCLC, suggesting a strategy to overcome this key SCLC immunologic barrier and prime therapeutic response to DLL3-targeted CAR-NK cell therapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318408">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE318867 è¡€ç®¡ STING æ¿€æ´»ä¿ƒè¿›å°ç»†èƒè‚ºç™Œä¸­ NK ç»†èƒçš„æŠ—è‚¿ç˜¤å…ç–« [ç©ºé—´è½¬å½•ç»„]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€NK cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Marco Campisi ; Ian Dryg ; Jason Weirather ; David A Barbie ; Navin R MahadevanSeries Type : OtherOrganism : Homo sapiensSmall cell lung cancer (SCLC) typically displays a &ldquo;cold&rdquo; tumor microenvironment with a paucity of immune infiltrate. Neuroendocrine SCLC cells also profoundly repress MHC-I expression, rendering them vulnerable to NK cell-mediated cytotoxicity. Here, we confirm that neuroendocrine SCLC cells are sensitive to NK cell mediated attack, yet quantitative spatial profiling of the SCLC immune microenvironment in patient samples reveals that effector immune cells, including NK cells, are excluded from MHC-Ilow/neg SCLC regions. To study this biology, we develop dynamic single cell RNA sequencing of microphysiological immune tumor environments (DynaMITE-seq) and integrate findings with spatial transcriptomics in patient tissue, unveiling the microvasculature as a major checkpoint restricting NK cell extravasation/recruitment. We demonstrate that activation of vascular Stimulator of Interferon Genes (STING) signaling restores NK cell infiltration and killing of neuroendocrine SCLC, suggesting a strategy to overcome this key SCLC immunologic barrier and prime therapeutic response to DLL3-targeted CAR-NK cell therapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318867">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE318663 è¡€ç®¡STINGæ¿€æ´»ä¿ƒè¿›NKç»†èƒåœ¨å°ç»†èƒè‚ºç™Œä¸­çš„æŠ—è‚¿ç˜¤å…ç–«</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€NK cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318663">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE319188 é€šè¿‡ LHRH-NanoTi é¶å‘é€’é€ TGF-Î² æŠ‘åˆ¶å‰‚å¯é€†è½¬åµå·¢ç™Œä¸­ NAT10/ac4C ä»‹å¯¼çš„é¡ºé“‚è¯±å¯¼çš„å…ç–«æŠ‘åˆ¶æ€§è‚¿ç˜¤å¾®ç¯å¢ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€tumor microenvironment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Fei LvSeries Type : OtherOrganism : Mus musculusBackground: Platinum-based chemotherapy for ovarian cancer is frequently compromised by the development of resistance, a process often accompanied by an immunosuppressive tumor microenvironment. The molecular mechanisms linking cisplatin resistance to immune evasion remain poorly understood, hindering the development of effective combination therapies.Results: This study reveals that cisplatin-induced immunosuppression and resistance are driven by a reduction in N-acetyltransferase 10 (NAT10)-mediated N4-acetylcytidine (ac4C) modification, which produces two parts of unfavorable effects: 1) activating the DNA damage repair pathway, thereby confers resistance to cisplatin; 2) enhancing the expression of TGF-Î² via NAT10&rsquo;s interaction with ribosomal proteins RPS3 and RPS6. The elevated TGF-Î² increases the infiltration of myeloid-derived suppressor cells (MDSCs), M2 macrophages, exhausted CD8+ T cells, and regulatory T cells (Tregs) within the tumor microenvironment. To target this pathway, we developed a LHRH receptor-targeted nanodelivery system for a TGF-Î² inhibitor, which synergized with cisplatin to achieve superior antitumor efficacy by effectively reversing the immunosuppressive microenvironment.Conclusions: Our study defines the NAT10/ac4Câ€“TGF-Î² axis as a pivotal mechanism coordinating cisplatin resistance and immunosuppression in ovarian cancer. These findings propose targeted inhibition of TGF-Î² signaling as a promising therapeutic strategy to overcome platinum resistance by revitalizing the antitumor immune response.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319188">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE318885 SMARCA4 é€šè¿‡ H3K27 ä¹™é…°åŒ–è°ƒèŠ‚ PROX1 ä¿ƒè¿›å‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œæ©æ‰å¢èƒºè€è¯æ€§ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chenwei Wu ; Mayao Luo ; Shidong Lv ; Qiang WeiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensEnzalutamide resistance is a dynamic process often culminating in the aggressive progression to neuroendocrine prostate cancer (NEPC). This lineage plasticity is hypothesized to be driven by underlying epigenetic alterations, yet the core molecular drivers remain unclear. Elucidating these factors is of significant clinical importance for overcoming resistance. To model this transition, we established a dynamic gradient-resistant cell model simulating the clinical response to enzalutamide, and found robust upregulation of the chromatin remodeling factor SMARCA4 in resistant cells. Both in vitro and in vivo experimental results demonstrated that inhibiting SMARCA4 effectively suppresses tumor progression and reverses neuroendocrine transformation. Mechanistically, integrated multi-omics analysis, correlation studies, and protein interaction experiments revealed the transcription factor PROX1 as a crucial downstream target of SMARCA4, where its inhibition alone was sufficient to reverse the aggressive malignancy and neuroendocrine characteristics of resistant cells. We further demonstrated that SMARCA4 enhances H3K27ac levels and chromatin accessibility at the PROX1 locus to regulate its expression. Importantly, the tumor-suppressive effect of SMARCA4 knockdown could be rescued by histone deacetylase inhibitors (HDACi), achieving a level of recovery comparable to PROX1 overexpression. In summary, this study defines a core epigenetic pathway, showing that increased SMARCA4 activity promotes luminal-to-neuroendocrine transformation by enhancing histone acetylation and chromatin accessibility at the PROX1 locus. Targeting the SMARCA4-PROX1 axis provides a valuable therapeutic strategy for combating enzalutamide resistance and NEPC progression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318885">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE318884 SMARCA4 é€šè¿‡ H3K27 ä¹™é…°åŒ–è°ƒæ§ PROX1 ä¿ƒè¿›å‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œæ©æ‰å¢èƒºè€è¯æ€§ [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chenwei Wu ; Mayao Luo ; Shidong Lv ; Qiang WeiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensEnzalutamide resistance is a dynamic process often culminating in the aggressive progression to neuroendocrine prostate cancer (NEPC). This lineage plasticity is hypothesized to be driven by underlying epigenetic alterations, yet the core molecular drivers remain unclear. Elucidating these factors is of significant clinical importance for overcoming resistance. To model this transition, we established a dynamic gradient-resistant cell model simulating the clinical response to enzalutamide, and found robust upregulation of the chromatin remodeling factor SMARCA4 in resistant cells. Both in vitro and in vivo experimental results demonstrated that inhibiting SMARCA4 effectively suppresses tumor progression and reverses neuroendocrine transformation. Mechanistically, integrated multi-omics analysis, correlation studies, and protein interaction experiments revealed the transcription factor PROX1 as a crucial downstream target of SMARCA4, where its inhibition alone was sufficient to reverse the aggressive malignancy and neuroendocrine characteristics of resistant cells. We further demonstrated that SMARCA4 enhances H3K27ac levels and chromatin accessibility at the PROX1 locus to regulate its expression. Importantly, the tumor-suppressive effect of SMARCA4 knockdown could be rescued by histone deacetylase inhibitors (HDACi), achieving a level of recovery comparable to PROX1 overexpression. In summary, this study defines a core epigenetic pathway, showing that increased SMARCA4 activity promotes luminal-to-neuroendocrine transformation by enhancing histone acetylation and chromatin accessibility at the PROX1 locus. Targeting the SMARCA4-PROX1 axis provides a valuable therapeutic strategy for combating enzalutamide resistance and NEPC progression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318884">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE319552 é…®ä½“å’Œç³–é…µè§£ä»£è°¢æ˜¯æ–°ç”Ÿå„¿è´¥è¡€ç—‡ç‚ç—‡çš„å…³é”®è°ƒèŠ‚å› å­</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : BjÃ¶rn Klabunde ; Ole BÃ¦k ; Duc Ninh NguyenSeries Type : Expression profiling by high throughput sequencingOrganism : Sus scrofaNeonatal sepsis is a life-threatening condition in preterm infants, primarily due to a dysregulated immunometabolic response to infection. Sepsis and infection mortality are associated with excessive glycolysis-induced inflammation, impaired mitochondrial oxidative phosphorylation (OXPHOS) and loss of disease tolerance. Reduced glucose intake can reverse these dysregulations, but it is unclear how the mechanistic control of glycolysis-OXPHOS balance drives defense strategies and infection outcomes. Here, in a preterm piglet model of neonatal sepsis, glycolysis inhibition with 2-deoxyglucose (2-DG) completely prevents acute infection mortality, reduces systemic inflammation and markers of liver injury, accompanied by enhanced mitochondrial metabolism and disease tolerance. Strikingly, this protection by 2-DG is conferred despite elevated blood glucose levels and higher bacterial burdens than the infected controls. Alternatively, partial replacement of glucose intake with the ketone beta-hydroxybutyrate (BHB) abolishes sepsis-related mortality via improving disease tolerance and clinical parameters.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319552">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE319314 å°èƒ¶è´¨ç»†èƒçº¿ç²’ä½“é€šè¿‡ä»£è°¢å’Œè½¬å½•é‡ç¼–ç¨‹æ”¯æŒäººç±»3Dä½“å¤–è„‘æ¨¡å‹ä¸­çš„ç¥ç»å…ƒæˆç†Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€Neuronal</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Sydney P Sterben ; Charitha C Anamala ; Sahan B Kansakar ; Vaishnavi Koduri ; Volha LiaudanskayaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAutism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by disrupted neuronal circuit maturation. Emerging evidence implicates microglial function and mitochondrial regulation as contributors to ASD-associated biology, yet the mechanisms linking these processes to neuronal development remain poorly defined. Neuronal maturation requires tightly coordinated metabolic and transcriptional remodeling, in which mitochondria play a central role in regulating the developmental tempo and metabolic identity, while microglia modulate neuronal synaptic network maturation; however, whether microglia influence neuronal development through direct mitochondrial contributions remains unknown. Here, using a 3D human in vitro brain model, we show that microglial mitochondria can act as transferable cues that promote metabolic, mitochondria-dynamic, and transcriptional aspects of neuronal maturation. Neurons treated with microglial mitochondria exhibited enhanced oxidative metabolism, improved mitochondrial dynamics, and activation of gene programs associated with nervous system development and neurogenesis. These effects were accompanied by increased expression of dendritic maturation markers, supporting the view that transferred mitochondria can contribute to the regulation of neuronal state. However, full structural and synaptic maturation required the combined action of microglia-derived mitochondria and secreted signaling factors. Together, this study identified microglial mitochondrial transfer as a contributor to neuronal maturation with potential relevance to developmental trajectories disrupted in ASD.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319314">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE319246 ApoE4 é€šè¿‡ AsxL1/LXRÎ±â€“H3K4me3 è½´çš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹é©±åŠ¨é˜¿å°”èŒ¨æµ·é»˜ç—…ä¸­çš„å°èƒ¶è´¨ç»†èƒè„‚è´¨å¤±è°ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimerã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground The Îµ 4 allele of apolipoprotein E gene (ApoE) stands as the greatest genetic risk factor for late-onset Alzheimerâ€™s disease (AD). Although microglia accumulating lipid droplets (LDAM) have been implicated in AD pathogenesis, the mechanistic link between ApoE4 and microglial lipid dysregulation remains elusive. Methods We employed a multi-omics approach, combining snRNA-seq and locus-specific epigenetic analysis, alongside microglia-specific gene manipulation in ApoE-targeted replacement (TR) mice. Primary microglia were challenged with cholesterol to simulate lipid overload conditions. Results In mid-life ApoE4-TR mice, microglia within the dentate gyrus developed pronounced lipid droplet accumulation, concurrent with impaired AÎ² clearance and a pro-inflammatory shift. snRNA-seq unveiled a unique microglial cluster in ApoE4 mice, enriched for lipid-metabolism genes and marked by the pronounced downregulation of the hub gene AsxL1. Mechanistically, ApoE4 attenuated the AsxL1â€“LXRÎ± interaction, leading to reduced H3K4me3 occupancy at promoters of lipid-efflux genes such as Abca1. Crucially, CRISPR-mediated, microglia-specific overexpression of AsxL1 restored H3K4me3 levels, normalized cholesterol efflux, and rescued AÎ² phagocytic deficits in vivo. Conclusions Our findings define an epigenetic pathway whereby ApoE4 drives microglial dysfunction via the AsxL1â€“LXRÎ±â€“H3K4me3 axis, fostering the LDAM phenotype. Enhancing AsxL1 function presents a promising therapeutic avenue for countering ApoE4-mediated pathogenesis in AD.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319246">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE319228 ä½“å†…æŠ‘åˆ¶å­å®«è‚Œç˜¤ä¸­çš„TDO2å¯¼è‡´è‚¿ç˜¤è½¬å½•ç»„å¹¿æ³›æ”¹å˜</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€transcriptome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tsai-Der Chuang ; Abigail Wiseman ; Gabriela Alfaro ; Sayna Pejouhesh Jahromi ; Sepideh Pejouhesh Jahromi ; Daniel Baghdasarian ; Omid KhorramSeries Type : Non-coding RNA profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensThis study aimed to characterize large and small RNA transcriptomic changes in fibroid xenografts from mice treated with the TDO2 inhibitor 680C91 for two months.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319228">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 24 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨4æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4><p><strong>1.</strong> <strong>å¤§å‹ç ”ç©¶å‘ç°ï¼Œå­•æœŸæ¥ç§mRNAæ–°å† ç–«è‹—ä¸è‡ªé—­ç—‡ä¹‹é—´æ²¡æœ‰å…³è”</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼švaccine</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers tracked more than 400 toddlers to see whether mRNA COVID-19 vaccination during or just before pregnancy was linked to autism or developmental delays. After detailed assessments of speech, motor skills, behavior, and social development, they found no meaningful differences between vaccinated and unvaccinated groups. Experts say the results provide strong reassurance about vaccine safety in pregnancy.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260215085001.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>äººå·¥æ™ºèƒ½æ­ç¤ºäº†é©±åŠ¨é˜¿å°”èŒ¨æµ·é»˜ç—…çš„éšè—åŸºå› æ§åˆ¶ä¸­å¿ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šScientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimerâ€™s disease. Using a powerful new AI-based system called SIGNET, the team uncovered cause-and-effect relationships between genes across six major brain cell types, revealing which genes are truly driving harmful changes. The most dramatic disruptions were found in excitatory neurons, where thousands of genetic interactions appear to be extensively rewired as the disease progresses.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260215084954.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>ç§‘å­¦å®¶å‘ç°ç¥ç»ä¼šç§¯æä¿ƒè¿›èƒ°è…ºç™Œçš„å‘ç”Ÿå‘å±•ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šScientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve fibers, which then release signals that accelerate early cancer growth. This creates a self-sustaining loop that helps tumors take hold. Blocking the nerve activity significantly reduced tumor growth in experiments, suggesting a new treatment strategy.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260211204208.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>ç§‘å­¦å®¶å‘ç°äº†ä¸€ç§èƒ½è®©ç™Œç»†èƒå¿«é€Ÿé‡ç¼–å…¶DNAçš„é…¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular structures, unleashing a burst of genetic changes that can help tumors rapidly adapt and resist therapy. Blocking the enzyme dramatically reduced this genomic destruction in cancer cells.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260215225546.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>cancer</td><td>9</td></tr><tr><td>tumor</td><td>5</td></tr><tr><td>RNA-seq</td><td>5</td></tr><tr><td>immunity</td><td>3</td></tr><tr><td>NK cell</td><td>3</td></tr><tr><td>metabolic</td><td>3</td></tr><tr><td>Alzheimer</td><td>2</td></tr><tr><td>scRNA</td><td>2</td></tr><tr><td>inflammation</td><td>2</td></tr><tr><td>Neuronal</td><td>2</td></tr><tr><td>transcriptome</td><td>2</td></tr><tr><td>sequencing</td><td>2</td></tr><tr><td>resistance</td><td>2</td></tr><tr><td>ATAC-seq</td><td>2</td></tr><tr><td>genomics</td><td>2</td></tr><tr><td>vaccine</td><td>1</td></tr><tr><td>scATAC</td><td>1</td></tr><tr><td>ChIP-seq</td><td>1</td></tr><tr><td>T cell</td><td>1</td></tr><tr><td>transcriptomics</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (24æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309579">GSE309579 æ•´åˆå•ç»†èƒ RNA å’Œ ATAC æµ‹åºæ­ç¤ºèƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­å‰‚é‡æ•æ„Ÿã€ç°‡ç‰¹å¼‚æ€§çš„è°ƒæ§åŠ¨æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294799">GSE294799 å¯¹å‘è‚²ä¸­çš„æ–‘é©¬é±¼å’Œäººç±»å†…èƒšå±‚è¿›è¡ŒåŠŸèƒ½åŸºå› ç»„å­¦åˆ†æï¼Œæ­ç¤ºäº†æ§åˆ¶è„Šæ¤åŠ¨ç‰©å™¨å®˜å‘ç”Ÿçš„é«˜åº¦ä¿å®ˆçš„é¡ºå¼è°ƒæ§æ¨¡å—[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294761">GSE294761 å¯¹å‘è‚²ä¸­çš„æ–‘é©¬é±¼å’Œäººç±»å†…èƒšå±‚è¿›è¡ŒåŠŸèƒ½åŸºå› ç»„å­¦åˆ†æï¼Œæ­ç¤ºäº†æ§åˆ¶è„Šæ¤åŠ¨ç‰©å™¨å®˜å‘ç”Ÿçš„é«˜åº¦ä¿å®ˆçš„é¡ºå¼è°ƒæ§æ¨¡å— [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254727">GSE254727 æ‹“æ‰‘ä¿¡æ¯è°ƒæ§å…ƒä»¶é›†åˆåè°ƒç»†èƒèº«ä»½åŸºå› è¡¨è¾¾ç¨‹åº[scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254726">GSE254726 æ‹“æ‰‘ä¿¡æ¯è°ƒæ§å…ƒä»¶é›†åˆåè°ƒç»†èƒèº«ä»½åŸºå› è¡¨è¾¾ç¨‹åº[scATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301801">GSE301801 å¯¹ç»å¯¹ç…§ç»„ã€èƒ†å›ºé†‡è¾…åŠ©æ­£å¸¸æ‰¹æ¬¡ã€æ¯’æ€§æ‰¹æ¬¡å’Œçš®è„‚é…¸å¤„ç†çš„é‡ç”Ÿå‹ C57BL/6 å°é¼ è¿›è¡Œæ‰¹é‡ RNA-seq åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298692">GSE298692 ChIP-seq åˆ†æ MM.1S ç»†èƒä¸­çš„ H3K4me3ã€H3K27acã€H3K27me3ã€p-STAT3ã€POU2AF1 å’Œ ELL2</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296093">GSE296093 mRNAç–«è‹—é€šè¿‡éå¸¸è§„é€”å¾„å¯åŠ¨CD8 Tç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162175">GSE162175 ä¸åŒå½¢å¼è¡°è€çš„è½¬å½•ç»„å­¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319394">GSE319394 ä½æ°§æ¡ä»¶ä¸‹ Siniperca chuatsi MFF-1 ç»†èƒçš„ RNA-seq åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319347">GSE319347 äººç±» iMGL å’Œ iMGL-è¿åŠ¨ç¥ç»å…ƒå…±åŸ¹å…»ç‰©ä¸ cGAS æŠ‘åˆ¶å‰‚çš„æ‰¹é‡ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319344">GSE319344 è„‘è†œæ·‹å·´ç®¡å†…çš®ç»†èƒçš„ä¸¢å¤±å¯¼è‡´å…·æœ‰æ¸…é™¤åŠŸèƒ½çš„æ–°å‹è¡€ç®¡ç½‘ç»œçš„å½¢æˆã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319333">GSE319333 éå°ç»†èƒè‚ºç™Œ (NSCLC) ä¸­ mtdsRNA æ°´å¹³çš„ç‰¹å¾åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319316">GSE319316 å±€éƒ¨è´Ÿåé¦ˆå¡‘é€ äº†å‡æ•°åˆ†è£‚DNAæ–­è£‚çš„å…¨åŸºå› ç»„æ¨¡å¼</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319292">GSE319292 æš´éœ²äºæŒç»­äºšæœ€å¤§å…è®¸æµ“åº¦ (MCL) å’Œè¶…æœ€å¤§å…è®¸æµ“åº¦ (MCL) äºšç ·é…¸é’ å’Œè´«é“€çš„æ–‘é©¬é±¼å¹¼ä½“è½¬å½•ç»„æ•°æ®</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319045">GSE319045 Irx3 é€šè¿‡è°ƒèŠ‚ç‚ç—‡å’Œçº¤ç»´åŒ–é€šè·¯æ”¹å–„å¿ƒè‚Œæ¢—æ­»åå¿ƒè„åŠŸèƒ½éšœç¢</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319035">GSE319035 P21+TREM2+-è¡°è€å·¨å™¬ç»†èƒä¿ƒè¿›ç‚ç—‡è¡°è€å’Œä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³çš„è„‚è‚ªè‚ç–¾ç—…[NAFLD_time_course]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319006">GSE319006 é¶å‘ HDAC å’Œè›‹ç™½è´¨ç¨³æ€ä»¥æ ¹é™¤é™æ­¢ç™Œç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318940">GSE318940 Smarca4 åè°ƒæŸ“è‰²è´¨å¯åŠæ€§å’Œä»£è°¢ç¨‹åºä»¥ç»´æŒé€ è¡€å¹²ç»†èƒåŠŸèƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318900">GSE318900 åˆ©ç”¨å¤§å‹è¯­è¨€æ¨¡å‹å’Œæ‰©æ•£æ¡†æ¶è§£ç å’Œé‡æ„å¯åŠ¨å­æ¶æ„ï¼šé«˜é€šé‡å¯åŠ¨å­å¼ºåº¦æµ‹åºæºæ•°æ®</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318654">GSE318654 äººç±»è„Šé«“èƒŒè§’å’Œè…¹è§’çš„åˆ†å­å›¾è°±å®šä¹‰äº†ç¥ç»å…ƒç±»å‹çš„æ’åˆ—å’Œç¥ç»èƒ¶è´¨ç»†èƒçš„æ€§åˆ«å·®å¼‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318004">GSE318004 NIK é©±åŠ¨çš„é«“ç³»ç»†èƒ IL-23 äº§ç”Ÿæ˜¯è‡ªèº«å…ç–«æ€§ç‚ç—‡å‘å±•çš„å…³é”®å› ç´  [16S rRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291249">GSE291249 åŒ¹é…çš„å·¦å¿ƒæˆ¿å’Œå³å¿ƒæˆ¿é¢¤åŠ¨äººç±»é˜Ÿåˆ—ä¸­DNAç”²åŸºåŒ–æ°´å¹³çš„è¡¨è§‚åŸºå› ç»„å­¦ç ”ç©¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290099">GSE290099 äººç±»å‰¯æµæ„Ÿç—…æ¯’3å‹æ„ŸæŸ“åäººè‚ºç»„ç»‡çš„å…ç–«ååº”â€”â€”ç»å…¸é€šè·¯å’Œæ²»ç–—</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-16 21:49</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week082026/ rel=tag>Week082026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-02-16/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-16</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-02-18/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-18</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-27/>ç§‘ç ”æ—¥æŠ¥ 2026-02-27</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-26/>ç§‘ç ”æ—¥æŠ¥ 2026-02-26</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-25/>ç§‘ç ”æ—¥æŠ¥ 2026-02-25</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-24/>ç§‘ç ”æ—¥æŠ¥ 2026-02-24</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-23/>ç§‘ç ”æ—¥æŠ¥ 2026-02-23</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (120)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (120)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week082026/ title=Week082026>Week082026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>